Blunted response of hippocampal AMPK associated with reduced neurogenesis in older versus younger mice

Sooah Jang, Hyunjeong Kim, Jihyeon Jeong, Su Kyoung Lee, Eun Woo Kim, Minsun Park, Chul Hoon Kim, Jongeun Lee, Kee Namkoong, Eosu Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The rate of hippocampal neurogenesis declines with aging. This is partly explained by decreased neural responsiveness to various cues stimulating metabolism. AMP-activated protein kinase (AMPK), a pivotal enzyme regulating energy homeostasis in response to metabolic demands, showed the diminished sensitivity in peripheral tissues during aging. AMPK is also known to be involved in neurogenesis. We aimed to see whether AMPK reactivity is also blunted in the aged hippocampus, and thus is associated with aging-related change in neurogenesis. Following subchronic (7 days) intraperitoneal and acute intracerebroventricular (i.c.v.) administration of either 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR; AMPK activator) or saline (sham) to young (16-week-old) and old (72-week-old) mice, we measured changes in AMPK activity, brain-derived neurotrophic factor (BDNF) expression or neurogenesis in the hippocampus. AICAR-induced changes in AMPK activity were observed in the hippocampus of young mice after acute i.c.v. injection. However, neither subchronic nor acute treatment induced significant changes in AMPK activity in old mice. Intriguingly, directions of AICAR-induced changes in AMPK activity were opposite between the hippocampus (decrease) and skeletal muscle (increase). ATP levels were inversely correlated with hippocampal AMPK activity, suggesting that the higher energy levels achieved by AICAR treatment might deactivate neuronal AMPK in young mice. The blunted response of AMPK to AICAR in old age was also indicated by the observations that the levels of neurogenesis and BDNF expression were significantly changed only in young mice upon AICAR treatment. Our findings suggest that the blunted response of neuronal AMPK in old age might be responsible for aging-associated decline in neurogenesis. Therefore, in addition to activation of AMPK, recovering its sensitivity may be necessary to enhance hippocampal neurogenesis in old age.

Original languageEnglish
Pages (from-to)57-65
Number of pages9
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume71
DOIs
Publication statusPublished - 2016 Nov 3

Fingerprint

AMP-Activated Protein Kinases
Neurogenesis
Hippocampus
Brain-Derived Neurotrophic Factor
Cues
AICA ribonucleotide
Skeletal Muscle
Homeostasis

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Biological Psychiatry

Cite this

Jang, Sooah ; Kim, Hyunjeong ; Jeong, Jihyeon ; Lee, Su Kyoung ; Kim, Eun Woo ; Park, Minsun ; Kim, Chul Hoon ; Lee, Jongeun ; Namkoong, Kee ; Kim, Eosu. / Blunted response of hippocampal AMPK associated with reduced neurogenesis in older versus younger mice. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2016 ; Vol. 71. pp. 57-65.
@article{fbfa8d2600a14cfbab0b13d8ea220f82,
title = "Blunted response of hippocampal AMPK associated with reduced neurogenesis in older versus younger mice",
abstract = "The rate of hippocampal neurogenesis declines with aging. This is partly explained by decreased neural responsiveness to various cues stimulating metabolism. AMP-activated protein kinase (AMPK), a pivotal enzyme regulating energy homeostasis in response to metabolic demands, showed the diminished sensitivity in peripheral tissues during aging. AMPK is also known to be involved in neurogenesis. We aimed to see whether AMPK reactivity is also blunted in the aged hippocampus, and thus is associated with aging-related change in neurogenesis. Following subchronic (7 days) intraperitoneal and acute intracerebroventricular (i.c.v.) administration of either 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR; AMPK activator) or saline (sham) to young (16-week-old) and old (72-week-old) mice, we measured changes in AMPK activity, brain-derived neurotrophic factor (BDNF) expression or neurogenesis in the hippocampus. AICAR-induced changes in AMPK activity were observed in the hippocampus of young mice after acute i.c.v. injection. However, neither subchronic nor acute treatment induced significant changes in AMPK activity in old mice. Intriguingly, directions of AICAR-induced changes in AMPK activity were opposite between the hippocampus (decrease) and skeletal muscle (increase). ATP levels were inversely correlated with hippocampal AMPK activity, suggesting that the higher energy levels achieved by AICAR treatment might deactivate neuronal AMPK in young mice. The blunted response of AMPK to AICAR in old age was also indicated by the observations that the levels of neurogenesis and BDNF expression were significantly changed only in young mice upon AICAR treatment. Our findings suggest that the blunted response of neuronal AMPK in old age might be responsible for aging-associated decline in neurogenesis. Therefore, in addition to activation of AMPK, recovering its sensitivity may be necessary to enhance hippocampal neurogenesis in old age.",
author = "Sooah Jang and Hyunjeong Kim and Jihyeon Jeong and Lee, {Su Kyoung} and Kim, {Eun Woo} and Minsun Park and Kim, {Chul Hoon} and Jongeun Lee and Kee Namkoong and Eosu Kim",
year = "2016",
month = "11",
day = "3",
doi = "10.1016/j.pnpbp.2016.06.011",
language = "English",
volume = "71",
pages = "57--65",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",

}

Blunted response of hippocampal AMPK associated with reduced neurogenesis in older versus younger mice. / Jang, Sooah; Kim, Hyunjeong; Jeong, Jihyeon; Lee, Su Kyoung; Kim, Eun Woo; Park, Minsun; Kim, Chul Hoon; Lee, Jongeun; Namkoong, Kee; Kim, Eosu.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 71, 03.11.2016, p. 57-65.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Blunted response of hippocampal AMPK associated with reduced neurogenesis in older versus younger mice

AU - Jang, Sooah

AU - Kim, Hyunjeong

AU - Jeong, Jihyeon

AU - Lee, Su Kyoung

AU - Kim, Eun Woo

AU - Park, Minsun

AU - Kim, Chul Hoon

AU - Lee, Jongeun

AU - Namkoong, Kee

AU - Kim, Eosu

PY - 2016/11/3

Y1 - 2016/11/3

N2 - The rate of hippocampal neurogenesis declines with aging. This is partly explained by decreased neural responsiveness to various cues stimulating metabolism. AMP-activated protein kinase (AMPK), a pivotal enzyme regulating energy homeostasis in response to metabolic demands, showed the diminished sensitivity in peripheral tissues during aging. AMPK is also known to be involved in neurogenesis. We aimed to see whether AMPK reactivity is also blunted in the aged hippocampus, and thus is associated with aging-related change in neurogenesis. Following subchronic (7 days) intraperitoneal and acute intracerebroventricular (i.c.v.) administration of either 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR; AMPK activator) or saline (sham) to young (16-week-old) and old (72-week-old) mice, we measured changes in AMPK activity, brain-derived neurotrophic factor (BDNF) expression or neurogenesis in the hippocampus. AICAR-induced changes in AMPK activity were observed in the hippocampus of young mice after acute i.c.v. injection. However, neither subchronic nor acute treatment induced significant changes in AMPK activity in old mice. Intriguingly, directions of AICAR-induced changes in AMPK activity were opposite between the hippocampus (decrease) and skeletal muscle (increase). ATP levels were inversely correlated with hippocampal AMPK activity, suggesting that the higher energy levels achieved by AICAR treatment might deactivate neuronal AMPK in young mice. The blunted response of AMPK to AICAR in old age was also indicated by the observations that the levels of neurogenesis and BDNF expression were significantly changed only in young mice upon AICAR treatment. Our findings suggest that the blunted response of neuronal AMPK in old age might be responsible for aging-associated decline in neurogenesis. Therefore, in addition to activation of AMPK, recovering its sensitivity may be necessary to enhance hippocampal neurogenesis in old age.

AB - The rate of hippocampal neurogenesis declines with aging. This is partly explained by decreased neural responsiveness to various cues stimulating metabolism. AMP-activated protein kinase (AMPK), a pivotal enzyme regulating energy homeostasis in response to metabolic demands, showed the diminished sensitivity in peripheral tissues during aging. AMPK is also known to be involved in neurogenesis. We aimed to see whether AMPK reactivity is also blunted in the aged hippocampus, and thus is associated with aging-related change in neurogenesis. Following subchronic (7 days) intraperitoneal and acute intracerebroventricular (i.c.v.) administration of either 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR; AMPK activator) or saline (sham) to young (16-week-old) and old (72-week-old) mice, we measured changes in AMPK activity, brain-derived neurotrophic factor (BDNF) expression or neurogenesis in the hippocampus. AICAR-induced changes in AMPK activity were observed in the hippocampus of young mice after acute i.c.v. injection. However, neither subchronic nor acute treatment induced significant changes in AMPK activity in old mice. Intriguingly, directions of AICAR-induced changes in AMPK activity were opposite between the hippocampus (decrease) and skeletal muscle (increase). ATP levels were inversely correlated with hippocampal AMPK activity, suggesting that the higher energy levels achieved by AICAR treatment might deactivate neuronal AMPK in young mice. The blunted response of AMPK to AICAR in old age was also indicated by the observations that the levels of neurogenesis and BDNF expression were significantly changed only in young mice upon AICAR treatment. Our findings suggest that the blunted response of neuronal AMPK in old age might be responsible for aging-associated decline in neurogenesis. Therefore, in addition to activation of AMPK, recovering its sensitivity may be necessary to enhance hippocampal neurogenesis in old age.

UR - http://www.scopus.com/inward/record.url?scp=84976309743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976309743&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2016.06.011

DO - 10.1016/j.pnpbp.2016.06.011

M3 - Article

VL - 71

SP - 57

EP - 65

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

ER -